Literature DB >> 10428858

Interactions between DNA helicases and frozen topoisomerase IV-quinolone-DNA ternary complexes.

M E Shea1, H Hiasa.   

Abstract

Collisions between replication forks and topoisomerase-drug-DNA ternary complexes result in the inhibition of DNA replication and the conversion of the normally reversible ternary complex to a nonreversible form. Ultimately, this can lead to the double strand break formation and subsequent cell death. To understand the molecular mechanisms of replication fork arrest by the ternary complexes, we have investigated molecular events during collisions between DNA helicases and topoisomerase-DNA complexes. A strand displacement assay was employed to assess the effect of topoisomerase IV (Topo IV)-norfloxacin-DNA ternary complexes on the DnaB, T7 gene 4 protein, SV40 T-antigen, and UvrD DNA helicases. The ternary complexes inhibited the strand displacement activities of these DNA helicases. Unlike replication fork arrest, however, this general inhibition of DNA helicases by Topo IV-norfloxacin-DNA ternary complexes did not require the cleavage and reunion activity of Topo IV. We also examined the reversibility of the ternary complexes after collisions with these DNA helicases. UvrD converted the ternary complex to a nonreversible form, whereas DnaB, T7 gene 4 protein, and SV40 T-antigen did not. These results suggest that the inhibition of DnaB translocation may be sufficient to arrest the replication fork progression but it is not sufficient to generate cytotoxic DNA lesion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428858     DOI: 10.1074/jbc.274.32.22747

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Endonuclease cleavage of blocked replication forks: An indirect pathway of DNA damage from antitumor drug-topoisomerase complexes.

Authors:  George Hong; Kenneth N Kreuzer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

2.  Replicative helicases can translocate through abasic site-induced covalent topoisomerase IV-DNA complexes.

Authors:  M E Shea; H Hiasa
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

3.  Effect of Moxifloxacin plus Pretomanid against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In Vitro Assay.

Authors:  Carolina de Miranda Silva; Amirhossein Hajihosseini; Jenny Myrick; Jocelyn Nole; Arnold Louie; Stephan Schmidt; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

4.  Lethal action of quinolones against a temperature-sensitive dnaB replication mutant of Escherichia coli.

Authors:  Xilin Zhao; Muhammad Malik; Nymph Chan; Alex Drlica-Wagner; Jian-Ying Wang; Xinying Li; Karl Drlica
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

Review 5.  Quinolone-mediated bacterial death.

Authors:  Karl Drlica; Muhammad Malik; Robert J Kerns; Xilin Zhao
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

Review 6.  Recombinational repair of DNA damage in Escherichia coli and bacteriophage lambda.

Authors:  A Kuzminov
Journal:  Microbiol Mol Biol Rev       Date:  1999-12       Impact factor: 11.056

7.  Norfloxacin-induced DNA gyrase cleavage complexes block Escherichia coli replication forks, causing double-stranded breaks in vivo.

Authors:  Jennifer Reineke Pohlhaus; Kenneth N Kreuzer
Journal:  Mol Microbiol       Date:  2005-06       Impact factor: 3.501

8.  Quinolone Resistance: Older Concepts and Newer Developments.

Authors:  Darrin J. Bast; Joyce C. S. de Azavedo
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.725

9.  Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.

Authors:  Arkady Mustaev; Muhammad Malik; Xilin Zhao; Natalia Kurepina; Gan Luan; Lisa M Oppegard; Hiroshi Hiasa; Kevin R Marks; Robert J Kerns; James M Berger; Karl Drlica
Journal:  J Biol Chem       Date:  2014-02-04       Impact factor: 5.157

10.  Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In Vitro Assay.

Authors:  Carolina de Miranda Silva; Amirhossein Hajihosseini; Jenny Myrick; Jocelyn Nole; Arnold Louie; Stephan Schmidt; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.